
DCM Shriram Fine Chemicals Q4 FY26 Results: Loss Rs 3.83 Cr
Updated: 20 May 2026 • 11:48 am
Posted by:

DCM Shriram Fine Chemicals Q4 FY26 results were declared on May 19, 2026. DCM Shriram Fine Chemicals reported net loss of Rs 3.83 crore down 186.7% YoY from Rs 4.13 crore in Q4 FY25, on revenue of Rs 93.08 crore for the quarter ended March 31, 2026. DCM Shriram Fine Chemicals is a Fine Chemicals company listed on Indian stock exchanges. This article covers the complete DCM Shriram Fine Chemicals Q4 FY26 financial highlights, key performance factors, and FY27 outlook for investors tracking DCM Shriram Fine Chemicals.
Click Here – Get Free Investment Predictions
DCM Shriram Fine Chemicals Q4 FY26 Financial Highlights
| Metric | Q4 FY26 | Notes |
|---|---|---|
| Net Loss | Rs 3.83 crore | down 186.7% YoY from Rs 4.13 crore in Q4 FY25 |
| Revenue | Rs 93.08 crore | for the quarter ended March 31, 2026 |
Note: Q4 FY26 net loss Rs 3.83 crore on revenue Rs 93.08 crore. Saccharin and chlorinated solvents manufacturer.
DCM Shriram Fine Chemicals Q4 FY26 Performance Analysis
The DCM Shriram Fine Chemicals Q4 FY26 results reflect DCM Shriram Fine Chemicals’s operational performance during the January to March 2026 quarter. The company operates in the Fine Chemicals space, a sector supported by India’s strong GDP growth and domestic demand. The Q4 FY26 loss reflects near-term challenges that management is expected to address in FY27.
Screen the best stocks on the Univest Screener.
Investors tracking DCM Shriram Fine Chemicals Q4 FY26 will focus on FY27 revenue guidance, margin trajectory, and management’s capital allocation commentary. Track DCM Shriram Fine Chemicals on the Univest Screener for live fundamentals and real-time updates.
Key Business Factors for DCM Shriram Fine Chemicals Q4 FY26
Revenue and Operational Performance
DCM Shriram Fine Chemicals Q4 FY26 performance reflects the January to March 2026 quarter, historically the year-end quarter with strong order execution and seasonality effects. India’s macroeconomic environment with GDP growth above 6.5% provided a constructive backdrop for the Fine Chemicals sector during this period.
Profitability and Margin Trends
The DCM Shriram Fine Chemicals Q4 FY26 net loss of Rs 3.83 crore down 186.7% YoY from Rs 4.13 crore in Q4 FY25. Management’s FY27 turnaround plan, cost efficiency measures, and revenue recovery pathway will be closely tracked by investors.
India Economic Context for DCM Shriram Fine Chemicals
The January to March 2026 quarter saw strong domestic consumption, fiscal year-end capital expenditure cycles, and government infrastructure spending. The Reserve Bank of India’s supportive monetary stance and India’s resilient growth trajectory provided a stable environment for listed companies across sectors. For DCM Shriram Fine Chemicals, operating in the Fine Chemicals space, this macro backdrop supported demand conditions during the quarter.
FY27 Outlook and Growth Drivers
Following the listed company results, management commentary on FY27 revenue guidance, capex plans, and order pipeline will be the primary catalysts for investor sentiment. The Fine Chemicals sector continues to benefit from India’s structural growth, rising domestic consumption, and government policy support.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Frequently Asked Questions on the group
What is DCM Shriram Fine Chemicals Q4 FY26 PAT?
Ans. the business PAT was net loss of Rs 3.83 crore down 186.7% YoY from Rs 4.13 crore in Q4 FY25. Results declared May 19, 2026. Verify from NSE/BSE filings before making investment decisions.
What is DCM Shriram Fine Chemicals Q4 FY26 revenue?
Ans. the firm revenue from operations was Rs 93.08 crore for the quarter ended March 31, 2026. Check the Univest Screener for live data.
When were DCM Shriram Fine Chemicals Q4 FY26 results announced?
Ans. the company results were announced on May 19, 2026, at the board of directors meeting approving audited Q4 and FY26 financial statements.
Is DCM Shriram Fine Chemicals a good investment after Q4 FY26?
Ans. Investment decisions require individual assessment of fundamentals, valuation, risk tolerance, and investment horizon. This article is for educational purposes only. Consult a SEBI-registered financial advisor before investing.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Recent Posts
PDS Q4 FY26 Results: PAT Rs 72 Cr, Revenue Rs 3,519 Crore
Hindustan Copper Q4 FY26 Results: PAT Rs 444 Cr, Revenue Rs 1,156 Crore
L&T Finance Analyst Review May 2026
NAVA Q4 FY26 Results: PAT Rs 136 Cr, Revenue Rs 1,143 Crore
Popular this week
PDS Q4 FY26 Results: PAT Rs 72 Cr, Revenue Rs 3,519 Crore
Hindustan Copper Q4 FY26 Results: PAT Rs 444 Cr, Revenue Rs 1,156 Crore
L&T Finance Analyst Review May 2026
NAVA Q4 FY26 Results: PAT Rs 136 Cr, Revenue Rs 1,143 Crore

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
